This review discusses the autoantibodies in pemphigus vulgaris and pemphigus foliaceus and the clinical and pathological similarities among these forms of pemphigus, bullous impetigo, and the staph ...

Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the Italian biotech company Pincell srl. JERUSALEM, June 26, 2025 /PRNewswire/ -- ...

Patients with pemphigus in complete remission had a reduced risk of relapse after receiving an additional rituximab infusion at month 6, according to a study.In the RITUX 3 trial, patients with ...

Pemphigus vulgaris is an autoimmune skin disease mediated by autoantibodies to desmoglein-3 (DSG3). Since the adult murine model of this disease is quite limited, researchers aimed to develop a novel ...

Different infectious diseases and immunizations can induce or exacerbate pemphigus, mainly by activating the cellular immune system. The nonself-antigen is presented to T lymphocytes and activates ...

COVID-19 infection increased the risk for autoimmune blistering diseases, but vaccination had protective effects, according to the results of a retrospective cohort study.